SEC of CDSCO recommends approval to Sputnik V for EUA in India
The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Subject Expert Committee
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
SEC recommends EUA for Covaxin from Bharat Biotech
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…
SEC meets to discuss EUA applications from Pfizer, SII and Bharat Biotech
To reconvene on Jan 1, 2021